In our research, both DPP4 activity and concentration were associated to more severe steatosis grade and inflammation at the biopsy whereas hepatic DPP4 expression was not influenced by liver damage in the course of NAFLD/NASH. This evidence concerns the gene DPP4 and metabolic dysfunction-associated steatohepatitis.